MAPK/ERK


The mitogen-activated protein kinase (MAPK) is a highly conserved family of serine/threonine kinases that mediate a board range of cellular processes, including proliferation, differentiation, motility, migration, stress response, apoptosis and survival. The activation of MAPK involves signaling pathways consisting of MAPK kinase (i.e. MAPKKK or MEKK) that activates MAPK/ERK (i.e. MAPKK or MEK). A variety of extracellular signals such as mitogens, cytokines, growth factors, and environmental stressors stimulate a phosphorylation-dependent increase in the activity of MAPK.
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B6187 BMS-582949Summary: p38 MAPK inhibitor -
B6188 Pamapimod (R-1503, Ro4402257)Summary: p38 MAPK inhibitor -
B7820 APS-2-79Summary: KSR-dependent MAPK modulator -
A1117 PKA inhibitor fragment (6-22) amideSummary: PKA inhibitor -
C3921 Ulixertinib (hydrochloride)Summary: reversible ERK1/2 inhibitor -
C3728 Sp-5,6-dichloro-cBIMPS (sodium salt)Summary: PKA activator -
C4338 AG-126Summary: ERK1 (p44) and ERK2 (p42) inhibitor -
C4361 PD 184161Summary: MEK1/2 inhibitor -
C4308 KemptideSummary: substrate for cAMP-dependent protein kinase (PKA) -
C4683 H-8 (hydrochloride)Summary: potent inhibitor of PKA and PKG

